PDT Partners’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

PDT Partners’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-119,400	Closed	-$1.07M	–	591
2016 Q3	$1.07M	Sell	119,400 -38,100	-24%	-$271K	0.06%	297
2016 Q2	$846K	Sell	157,500 -1,400	-0.9%	-$7.18K	0.07%	275
2016 Q1	$731K	Buy	158,900 +63,400	+66%	+$255K	0.05%	348
2015 Q4	$497K	Buy	+95,500	New	+$554K	0.07%	275
2015 Q3	–	Sell	-70,330	Closed	-$1.11M	–	1823
2015 Q2	$1.11M	Buy	+70,330	New	+$854K	0.03%	708
2013 Q4	–	Sell	-16,200	Closed	-$242K	–	1528
2013 Q3	$242K	Buy	+16,200	New	+$194K	0.01%	1339

PDT Partners's RPTP Position: Q4 2016 in Review

PDT Partners sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 119,400 shares — an estimated $1.07M sold.

PDT Partners first reported a position in RPTP in Q3 2013 and held it in 6 quarters. The position peaked at $1.11M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

PDT Partners reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
PDT Partners sold 119,400 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.07M.
PDT Partners first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 6 quarters.
PDT Partners's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.11M in Q2 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on PDT Partners's 13F filing for Q4 2016, filed 14 Feb 2017.